Phytopharmaceuticals: India’s growing market potential

India’s phytopharmaceutical industry is uniquely positioned in the global market due to its vast biodiversity, encompassing over 7,500 medicinal plant species, and a deep-rooted foundation in traditional medicinal systems such as Ayurveda, Siddha, and Unani. Recent regulatory advancements, including the 2015 amendment to the Drugs and Cosmetics Act, and innovations in biotechnology and nanotechnology have elevated the quality, safety, and efficacy of Indian phytopharmaceuticals. The sector’s growth contributes significantly to economic development and healthcare access, particularly for chronic disease management. Addressing quality standardization and intellectual property protection will further strengthen India’s potential as a global leader in plant-based therapeutics.